X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
female (11) 11
middle aged (10) 10
oncology (10) 10
adult (9) 9
breast cancer (8) 8
cancer (7) 7
chemotherapy (7) 7
aged (6) 6
index medicus (6) 6
male (5) 5
breast neoplasms - drug therapy (4) 4
diagnosis (4) 4
endothelium (4) 4
medicine & public health (4) 4
therapy (4) 4
trastuzumab (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
breast neoplasms - pathology (3) 3
cardiac & cardiovascular systems (3) 3
case report (3) 3
disease-free survival (3) 3
docetaxel (3) 3
expression (3) 3
hypercholesterolaemia (3) 3
patients (3) 3
retrospective studies (3) 3
5-fluorouracil (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
anxa1 (2) 2
biomarker (2) 2
brca1 (2) 2
brca1 protein (2) 2
brca2 (2) 2
carcinoma (2) 2
cav-1 (2) 2
clinical trials (2) 2
continuous-infusion (2) 2
dasatinib (2) 2
deoxyribonucleic acid--dna (2) 2
drug administration schedule (2) 2
dysfunction (2) 2
endothelium, vascular - physiopathology (2) 2
epha2 (2) 2
erbb-2 protein (2) 2
estrogen (2) 2
family medical history (2) 2
folic acid (2) 2
forearm - blood supply (2) 2
genes (2) 2
genetic testing (2) 2
hereditary breast cancer (2) 2
hypercholesterolemia - physiopathology (2) 2
hyperemia - physiopathology (2) 2
melanoma (2) 2
metastases (2) 2
monoclonal-antibody (2) 2
mutation (2) 2
neoplasm invasiveness (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
ngs (2) 2
nitric-oxide (2) 2
panel (2) 2
phase-ii (2) 2
phase-ii trial (2) 2
prevalence (2) 2
reactive hyperemia (2) 2
regional blood flow - drug effects (2) 2
risk factors (2) 2
statins (2) 2
surgery (2) 2
survival rate (2) 2
treatment outcome (2) 2
vasodilation - drug effects (2) 2
vinblastine - adverse effects (2) 2
vinblastine - analogs & derivatives (2) 2
vinorelbine (2) 2
1-phosphatidylinositol 3-kinase (1) 1
1506 (1) 1
1st-line chemotherapy (1) 1
5-year analysis (1) 1
adenosine (1) 1
adjuvant chemotherapy (1) 1
administración de bases de datos (1) 1
administration, oral (1) 1
age (1) 1
age distribution (1) 1
akt protein (1) 1
algorithmic knowledge discovery (1) 1
analysis (1) 1
analysis of variance (1) 1
androgen receptor (1) 1
androgens (1) 1
angiogenesis (1) 1
annexin v (1) 1
anthracycline (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibody (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


memo - Magazine of European Medical Oncology, ISSN 1865-5041, 2/2014, Volume 7, Issue 1, pp. 47 - 49
Chemotherapy and targeted agents, such as small molecules and monoclonal antibodies, have individually improved cancer medical therapeutics, yet there is still... 
Targeted therapies | Medicine & Public Health | Antibody–drug conjugates | Clinical trials | Oncology | Future perspectives | Medicine/Public Health, general | Antibody-drug conjugates | Antimitotic agents | Chemotherapy | Leukemia | Monoclonal antibodies | Antineoplastic agents | Spyware | Biopharmaceutics | Cancer
Journal Article
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 5/2019, Volume 145, Issue 5, pp. 1221 - 1233
Androgen receptor (AR) is playing an important role in the progression of a subset of TNBC. We evaluated the impact of ERβ expression along with anti-AR drugs... 
Medicine & Public Health | Hematology | Estrogen receptor β (ER β ) | Androgen receptor | Oncology | Cancer Research | Internal Medicine | Bicalutamide | Enzalutamide | Triple-negative breast cancer | ONCOLOGY | Estrogen receptor (ER) | EXPRESSION | Proteins | Phenols | Androgens | Breast cancer | Estrogen
Journal Article
Journal Article
Case Reports in Oncology, ISSN 1662-6575, 08/2018, Volume 11, Issue 2, pp. 557 - 561
Aromatase inhibitors (AIs) are a commonly used antihormonal therapy in the treatment of breast cancer in postmenopausal women, specifically in the treatment of... 
Case Report | Tendinopathy | Muscle tendon rupture | Breast cancer | Aromatase inhibitor | Enzymes | Nuclear magnetic resonance--NMR | Medical imaging | Systemic diseases | Menopause | Mortality | Rheumatology | Estrogen | Metastasis | Radiation therapy | Patients | Cancer therapies | Osteoporosis | Chemotherapy | Fractures | Pain | Womens health | Mastectomy | Hormone replacement therapy | Health risk assessment
Journal Article
Journal Article
Clinical breast cancer, ISSN 1526-8209, 08/2019
BRCA1/BRCA2 mutation carriers indefinitely comprise a distinct group of patients with breast cancer (BC), with their tumors displaying specific pathologic... 
Journal Article
Journal Article
Anticancer Research, ISSN 0250-7005, 08/2012, Volume 32, Issue 8, pp. 3311 - 3314
Breast cancer (BC), the most common type of cancer in women of the Western world, is often associated with para paraneoplastic syndromes (PNS). Autoimmune... 
Paraneoplastic autoimmune pancreatitis | Case report | Breast cancer | ONCOLOGY | CEREBELLAR DEGENERATION | breast cancer | case report | ANTIBODY | PATIENT | CARCINOMA | Breast Neoplasms - complications | Paraneoplastic Syndromes - complications | Humans | Autoimmune Diseases - complications | Adult | Female | Pancreatitis - complications
Journal Article
Journal Article
Journal Article
International Journal of Clinical and Experimental Medicine, ISSN 1940-5901, 03/2013, Volume 6, Issue 3, pp. 211 - 218
Purpose: We present the case of a patient treated for intracranial germ cell tumor in which elements of craniopharyngioma were found in the residual tumor... 
Germ cell tumor | Intracranial | Dysembryogenesis | Craniopharyngioma | MEDICINE, RESEARCH & EXPERIMENTAL | DIAGNOSIS | CARBOPLATIN | MANAGEMENT | dysembryogenesis | germ cell tumor | IFOSFAMIDE | CANCER | CHEMOTHERAPY | ETOPOSIDE | TERATOMA | craniopharyngioma
Journal Article
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 10/2005, Volume 28, Issue 11, pp. 558 - 564
Background: Trastuzumab has been repeatedly shown to result in significant clinical benefits and was subsequently accepted as the treatment of choice for... 
Original Article · Originalarbeit | Trastuzumab, 3-weekly | Efficacy | Breast cancer, metastatic | Safety | HER2/NEU-OVEREXPRESSING METASTATIC BREAST | VINORELBINE | MONOCLONAL-ANTIBODY | ANTITUMOR-ACTIVITY | DOCETAXEL | efficacy | PACLITAXEL | trastuzumab, 3-weekly | PHASE-II TRIAL | COMBINATIONS | THERAPY | ONCOLOGY | safety | PHARMACOLOGY | breast cancer, metastatic | Risk Assessment - methods | Age Distribution | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - administration & dosage | Vinblastine - administration & dosage | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Vinblastine - adverse effects | Drug-Related Side Effects and Adverse Reactions | Adult | Deoxycytidine - adverse effects | Female | Taxoids - adverse effects | Breast Neoplasms - epidemiology | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Neoplasm Recurrence, Local - metabolism | Neoplasm Recurrence, Local - prevention & control | Deoxycytidine - administration & dosage | Risk Factors | Survival Rate | Treatment Outcome | Greece - epidemiology | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Antibodies, Monoclonal - administration & dosage | Sex Distribution | Aged | Neoplasm Recurrence, Local - epidemiology | Deoxycytidine - analogs & derivatives | Trastuzumab
Journal Article